These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 20519122)

  • 1. PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss.
    Wei W; Wang X; Yang M; Smith LC; Dechow PC; Sonoda J; Evans RM; Wan Y
    Cell Metab; 2010 Jun; 11(6):503-16. PubMed ID: 20519122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual targeting of SREBP2 and ERRα by carnosic acid suppresses RANKL-mediated osteoclastogenesis and prevents ovariectomy-induced bone loss.
    Zheng ZG; Cheng HM; Zhou YP; Zhu ST; Thu PM; Li HJ; Li P; Xu X
    Cell Death Differ; 2020 Jul; 27(7):2048-2065. PubMed ID: 31907393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARγ in bone homeostasis.
    Wan Y
    Trends Endocrinol Metab; 2010 Dec; 21(12):722-8. PubMed ID: 20863714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of selective PPARγ modulators in the differentiation of osteoclasts.
    Wu H; Li L; Ma Y; Chen Y; Zhao J; Lu Y; Shen P
    J Cell Biochem; 2013 Sep; 114(9):1969-77. PubMed ID: 23494891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss.
    Fukunaga T; Zou W; Rohatgi N; Colca JR; Teitelbaum SL
    J Bone Miner Res; 2015 Mar; 30(3):481-8. PubMed ID: 25257948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways.
    Abdelkarim M; Caron S; Duhem C; Prawitt J; Dumont J; Lucas A; Bouchaert E; Briand O; Brozek J; Kuipers F; Fievet C; Cariou B; Staels B
    J Biol Chem; 2010 Nov; 285(47):36759-67. PubMed ID: 20851881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of beta-lapachone on RANKL-induced osteoclastogenesis.
    Gu DR; Lee JN; Oh GS; Kim HJ; Kim MS; Lee SH
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1073-1079. PubMed ID: 27913299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGC1β Organizes the Osteoclast Cytoskeleton by Mitochondrial Biogenesis and Activation.
    Zhang Y; Rohatgi N; Veis DJ; Schilling J; Teitelbaum SL; Zou W
    J Bone Miner Res; 2018 Jun; 33(6):1114-1125. PubMed ID: 29521005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organotins are potent activators of PPARγ and adipocyte differentiation in bone marrow multipotent mesenchymal stromal cells.
    Yanik SC; Baker AH; Mann KK; Schlezinger JJ
    Toxicol Sci; 2011 Aug; 122(2):476-88. PubMed ID: 21622945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic peroxisome proliferator-activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes.
    Petrovic N; Walden TB; Shabalina IG; Timmons JA; Cannon B; Nedergaard J
    J Biol Chem; 2010 Mar; 285(10):7153-64. PubMed ID: 20028987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma regulates bone remodeling after midpalatal suture expansion in mice.
    Wu J; Ru N; Li S
    Int J Oral Maxillofac Implants; 2015; 30(6):1423-30. PubMed ID: 26478981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue of neurons from ischemic injury by peroxisome proliferator-activated receptor-gamma requires a novel essential cofactor LMO4.
    Schock SC; Xu J; Duquette PM; Qin Z; Lewandowski AJ; Rai PS; Thompson CS; Seifert EL; Harper ME; Chen HH
    J Neurosci; 2008 Nov; 28(47):12433-44. PubMed ID: 19020036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPAR agonists stimulate adipogenesis at the expense of osteoblast differentiation while inhibiting osteoclast formation and activity.
    Patel JJ; Butters OR; Arnett TR
    Cell Biochem Funct; 2014 Jun; 32(4):368-77. PubMed ID: 24615887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor γ-independent mitochondrial oxidative stress in mouse hearts.
    He H; Tao H; Xiong H; Duan SZ; McGowan FX; Mortensen RM; Balschi JA
    Toxicol Sci; 2014 Apr; 138(2):468-81. PubMed ID: 24449420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermogenically competent nonadrenergic recruitment in brown preadipocytes by a PPARgamma agonist.
    Petrovic N; Shabalina IG; Timmons JA; Cannon B; Nedergaard J
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E287-96. PubMed ID: 18492776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
    Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
    J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. n-3 polyunsaturated fatty acids stimulate osteoclastogenesis through PPARγ-mediated enhancement of c-Fos expression, and suppress osteoclastogenesis through PPARγ-dependent inhibition of NFkB activation.
    Nakanishi A; Tsukamoto I
    J Nutr Biochem; 2015 Nov; 26(11):1317-27. PubMed ID: 26303404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoclast progenitors reside in the peroxisome proliferator-activated receptor γ-expressing bone marrow cell population.
    Wei W; Zeve D; Wang X; Du Y; Tang W; Dechow PC; Graff JM; Wan Y
    Mol Cell Biol; 2011 Dec; 31(23):4692-705. PubMed ID: 21947280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dysfunction of hepatic transcriptional factors in mice with Huntington's Disease.
    Chiang MC; Chern Y; Juo CG
    Biochim Biophys Acta; 2011 Sep; 1812(9):1111-20. PubMed ID: 21651979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K/AKT phosphorylation activates ERRα by upregulating PGC‑1α and PGC‑1β in gallbladder cancer.
    Wang L; Yang M; Jin H
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.